Iran vs Togo: The number of people with susceptibility test result for rifampicin
Iran
1,828
in 2021
Togo
1,805
in 2021
Iran rank
51st
Togo rank
52nd
The number of people with susceptibility test result for rifampicin over time
- Iran
- Togo
How they compare
Iran currently reports 1,828 against 1,805 in Togo, a difference of 23.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Iran ahead.
Iran ranks 51st and Togo ranks 52nd of 155 countries.
Across the 2 decades both report, Iran averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Iran | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,008 | 732 | 2,276 | Iran |
| 2020s | 1,608 | 1,709 | 101.5 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Iran or Togo?
- Iran, at 1,828 against 1,805 in Togo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Iran and Togo?
- 23, with Iran ahead.
- How many years of comparable data are there for Iran and Togo?
- 5 years are reported by both, from 2017 to 2021.
- How do Iran and Togo rank globally for the number of people with susceptibility test result for rifampicin?
- Iran ranks 51st and Togo ranks 52nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.